Indian equity markets are likely to open higher on Thursday, tracking gains in global markets. At 6:46 a.m., GIFT Nifty was trading 22 points higher at 25,650, indicating a firm start for the Sensex and Nifty.
Investors will track developments in Sanofi India, IRFC, RVNL, Lupin, TCS, RIL and other companies amid updates on earnings, dividends, project awards and regulatory actions.
Sanofi India reported a fourth-quarter net profit of Rs 61.7 crore, compared with Rs 91.3 crore in the corresponding period a year earlier. Revenue from operations stood at Rs 419.8 crore, down from Rs 514.9 crore a year ago.
KSB reported a fourth-quarter net profit of Rs 10.8 crore, compared with Rs 73 crore in the year-ago period. Revenue from operations rose to Rs 784 crore from Rs 726.4 crore a year earlier.
SBI Life Insurance announced an interim dividend of Rs 2.7 per equity share of face value Rs 10, as approved by its board.
In IRFC, the Government of India, as promoter, has decided not to exercise the oversubscription option for an additional 2 percent stake. In the initial offering on February 25, there was a shortfall of 1.18 crore shares.
KFin Technologies and Computer Age Management Services’ joint venture, MFC Technologies, announced key leadership appointments. MF Central is transitioning into a professionally managed independent entity serving India’s mutual fund sector.
RIL said that following the allotment of shares to a unit of technology company Meta, Reliance Enterprise Intelligence Limited has become an indirect subsidiary of the company.
Tata Consultancy Services said it wants employees to actively use artificial intelligence even if it impacts existing revenue streams. The statement comes amid industry discussions on AI-driven billing models and employment implications.
The Maharashtra Goods and Services Tax Department has initiated inspection and search proceedings at the registered office of Mumbai-based Lupin starting February 25, 2026. Documents related to tax payments and input tax credit have been sought.
Lodha Developers acquired development rights for a property in Mumbai for approximately Rs 106.12 crore.
Dr. Reddy’s Laboratories may launch a generic version of semaglutide injection under the brand name ‘Obeda’ in the country in March.
Shaily Engineering Plastics entered into an agreement with a domestic pharmaceutical company for the manufacturing and commercial supply of pen injectors. The contract is valued at approximately Rs 423 crore and will be executed over four years. The company stated that promoters have no interest in the transaction and that it is not a related party transaction.
KP Energy received a letter of award from Enarpark Energy for the development of a 40.8 MW wind-solar hybrid power project in Gujarat. The project comprises approximately 20.2 MW of wind capacity and 20.6 MW of solar capacity.
Rail Vikas Nigam Limited received a letter of award from National Mineral Development Corporation for the development of a township in Kirandul, Chhattisgarh.
